SCHEMBL23830339

SCHEMBL23830339

CCOC(=O)c1nn(Cc2ncnc(N3CCOCC3)c2C)c2cc(C)cnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.41
RXFP1 Q9HBX9 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
PKM P14618 1/20 0.40
PIK3CA P42336 1/20 0.39
HTR2C P28335 1/20 0.39
MAPT P10636 3/20 0.38
GAA P10253 2/20 0.38
THRB P10828 1/20 0.37
TP53 P04637 2/20 0.37
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
MTOR P42345 2/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830356 0.89 PDE10A (0.36) L3MBTL1PKMGAAHSD17B10KDM4E
SCHEMBL23830355 0.82 PDE6D (0.35) THRBTP53HSD17B10KDM4EALDH1A1
SCHEMBL23830349 0.81 PDE6D (0.38) MAPTTP53MAPK1HSD17B10KDM4E
SCHEMBL23830352 0.81 PDE6D (0.44) HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL23830317 0.81 PDE6D (0.37) L3MBTL1MAPTGAAKDM4EALDH1A1
SCHEMBL23830385 0.81 PDE6D (0.52) HSD17B10SMN1; SMN2
SCHEMBL23830296 0.80 PDE6D (0.37) ALOX15TP53ALDH1A1TSHRSMN1; SMN2
SCHEMBL23830357 0.78 PDE6D (0.40)
SCHEMBL23830376 0.78 PDE6D (0.45) GAAHSD17B10TSHRSMN1; SMN2
SCHEMBL23830370 0.73 PDE6D (0.44) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA CADILA HEALTHCARE LIMITED (IN) 2021-09-23 US disclosed
CN-112543757-A Condensed azaheteroaryl compounds having antibacterial activity against tubercle bacillus 卡迪拉保健有限公司 2021-03-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA DPEP1, SAT1, PEPD ALOX15 1304/4885RXFP1 1211/4885L3MBTL1 2355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.